Voveran D Tablet (10) Information
Voveran D Tablet (10) is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Muscle Pain, Toothache, Rheumatic Pain. Secondary and off-label uses of Voveran D Tablet (10) have also been mentioned below.
The correct dosage of Voveran D Tablet (10) depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Some other side effects of Voveran D Tablet (10) have been listed ahead. Usually, these side effects of Voveran D Tablet (10) go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Voveran D Tablet (10) has a Severe effect for pregnant women and Mild effect on lactating mothers. Further, the section on Voveran D Tablet (10) related warnings talks about Voveran D Tablet (10)'s effects on the liver, heart and kidney.
Voveran D Tablet (10) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Voveran D Tablet (10) in conditions like Stomach Infection, Skin Rash, Stroke. Other conditions have been mentioned below in the Voveran D Tablet (10) contraindications section.
Drug reaction of Voveran D Tablet (10) with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Voveran D Tablet (10), it is important to know that it is safe while driving, and is habit-forming.
Voveran D Tablet (10) Benefits & Uses
Voveran D Tablet (10) is used to treat the following -
Main Benefits
- Muscle Pain (Read More - Home Remedies for Muscle Aches)
- Toothache (Read More - Home remedies for toothache)
- Rheumatic Pain
Other Benefits
- Headache
- Joint Pain (Read More - How to Relieve Joint Pain Naturally: Best Home Remedies)
- Osteoarthritis
- Rheumatoid Arthritis
- Ankylosing spondylitis
- Gout (Read More - Home remedies for gout pain)
- Migraine (Read More - Home remedies for migraines)
- Leg Pain (Read More - Home remedies for leg pain and weakness)
- Body Pain (Read More - Home Remedies for Body Pain)
- Sciatica (Read More - Home Remedies for Sciatica: Alleviate Pain Naturally)
- Foot Pain (Read More - How to Ease Foot Pain at Home with Natural Techniques)
Voveran D Tablet (10) Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Voveran D Tablet (10) Side Effects
Based on research, the following side effects have been observed when Voveran D Tablet (10) is used -
Severe
- Nephrotoxic
- Constipation (Read More - Home remedies for constipation)
- Diarrhoea
- Pancreatic inflammation
- Liver Damage
Moderate
- Fluid Retention
- पेट दर्द
- Arrhythimia
Mild
- Skin Rash (Read More - DIY Skin Rash Relief: Simple Home Remedies That Work)
- Nausea or vomiting
Voveran D Tablet (10) Related Warnings
-
Is the use of Voveran D Tablet (10) safe for pregnant women?
Pregnant women may get severe side effects after taking Voveran. If you are pregnant, do not take Voveran without a doctor's advice.
Severe -
Is the use of Voveran D Tablet (10) safe during breastfeeding?
Voveran may have very limited harmful effects for breastfeeding women.
Mild -
What is the effect of Voveran D Tablet (10) on the Kidneys?
There may be some severe side effects of Voveran on your kidney. Do not take it unless a doctor says so.
Severe -
What is the effect of Voveran D Tablet (10) on the Liver?
Voveran can cause side effects that could harm the liver. So medical advice before taking it is necessary.
Severe -
What is the effect of Voveran D Tablet (10) on the Heart?
Voveran may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Moderate
Severe Interaction of Voveran D Tablet (10) with Other Drugs
Voveran D Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Voveran D Tablet (10) Contraindications
If you are suffering from any of the following diseases, you should not take Voveran D Tablet (10) unless your doctor advises you to do so -
- Edema
- Stomach Infection
- Gastrointestinal Bleeding
- Kidney Disease
- Skin Rash
- Heart Attack
- Stroke
- Asthma
- Anemia
- Heart Failure
- Liver Disease
- Peptic Ulcer
Frequently asked Questions about Voveran D Tablet (10)
-
Is this Voveran D Tablet (10) habit forming or addictive?
Forming a habit of Voveran D Tablet (10) has not been reported.
No -
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Voveran D Tablet (10) since it will not make you feel sleepy.
Safe -
Is it safe?
Yes, but take Voveran D Tablet (10) only as per medical advice.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
No, Voveran D Tablet (10) is not used to treat mental disorders.
No
Voveran D Tablet (10) Interactions with Food and Alcohol
-
Interaction between Food and Voveran D Tablet (10)
There isn't any research available on the side effects of taking Voveran D Tablet (10) with food.
Unknown -
Interaction between Alcohol and Voveran D Tablet (10)
Taking Voveran D Tablet (10) with alcohol can have severely harmful effects on your health.
Severe
See all substitutes for Voveran
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
